Editas Medicine (EDIT) Prepaid Assets (2015 - 2025)
Editas Medicine's (EDIT) quarterly Prepaid Assets came in at $2.1 million in Q4 2025, down 33.86% year-on-year from $3.1 million in Q4 2024, and down 33.38% on a QoQ basis from $3.1 million in Q3 2025.
Editas Medicine (EDIT) Prepaid Assets (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Prepaid Assets data on file, last reported at $2.1 million in Q4 2025.
- On a quarterly basis, Prepaid Assets fell 33.86% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 33.86% decrease from a year earlier, with the FY2025 full-year figure at $2.1 million, down 33.86% from the prior year.
- Prepaid Assets for Q4 2025 stood at $2.1 million, down from $3.1 million in the prior quarter.
- Over the last five years, Prepaid Assets for EDIT reached as high as $9.5 million in Q3 2021 and fell as low as $2.1 million in Q4 2025.
- Historically, Prepaid Assets has averaged $6.1 million across 5 years, with a median of $6.6 million in 2023.
- Across the five-year window, Prepaid Assets jumped 58.2% in 2024 and sank 63.14% in 2025, its largest moves.
- Year by year, Prepaid Assets stood at $7.2 million in 2021, then advanced by 1.9% to $7.3 million in 2022, then advanced by 2.67% to $7.5 million in 2023, then tumbled by 58.36% to $3.1 million in 2024, then plunged by 33.86% to $2.1 million in 2025.
- Per Business Quant data, the three most recent Prepaid Assets figures were $2.1 million in Q4 2025, $3.1 million in Q3 2025, and $3.7 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Editas Medicine | 245.95 Mn | 99.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.07 Mn |
| Sep 30, 2025 | 3.11 Mn |
| Jun 30, 2025 | 3.71 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 5.93 Mn |
| Jun 30, 2024 | 7.00 Mn |
| Mar 31, 2024 | 9.14 Mn |
| Dec 31, 2023 | 7.53 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 6.72 Mn |
| Mar 31, 2023 | 5.78 Mn |
| Dec 31, 2022 | 7.34 Mn |
| Sep 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 8.11 Mn |
| Mar 31, 2022 | 7.30 Mn |
| Dec 31, 2021 | 7.20 Mn |
| Sep 30, 2021 | 9.52 Mn |
| Jun 30, 2021 | 5.41 Mn |
| Mar 31, 2021 | 6.31 Mn |